March 2012 - Allergies in a changing environment in Europe

Allergies are the most prevalent chronic diseases in Europe with a frequency > 20%. Allergic diseases to airborne allergens have been steadily increasing over the past few decades and an end to this increase is not in sight. Especially the younger generations show a higher incidence of allergic diseases. Thus, by the year 2040, 40% of the population will present an allergic predisposition in Europe.

The reasons for this steady increase are unclear. The Interest Group Aerobiology and Air Pollution of the EAACI (European Academy of Allergy and Clinical Immunology) organised a workshop on Wednesday, 21 March 2012, to inform stakeholders about the ongoing and future developments in allergy research in Europe to increase the public awareness for this ongoing epidemic.

This workshop gave up-to-date information about:
1. Current status of allergic diseases in Europe
2. Drivers of this allergic epidemic, including neophytes like Ambrosia artimisiifolia
3. Ongoing EU-funded projects on allergic diseases, like HIALINE
4. Highlight novel developments
5. Identify scientific areas that need additional EU-attention
6. Round table public discussion

Renowned speakers, researchers and opinion leaders in the investigation of allergic diseases took part in this meeting.

Participants: EU-Members of Parliament, EU-scientific officers, journalists, representatives of patient organisations and other interested stakeholders

On behalf of the Organising Committee,
Prof. Dr. J. Buters
Secretary of the Interest Group Aerobiology and Air Pollution
Last updated 06 May 2016
EAACI's EU liaison office in Brussels acts as the contact point for internal and external EAACI EU Affairs relations.
EAACI – EU Liaison Office
Rue du Luxembourg, 22-24
B-1000 Brussels
Tel : +32 (2)2 761 66 83


As the leading European medical society focusing on allergy, EAACI has a key role to play in the formulation of health and research policies at the European level. EAACI activities focus on improving allergy care, fostering allergy research and help strengthen Allergology as a medical specialty.

By being present in Brussels, EAACI aims to establish allergy ambassadors among EU Parliament members and to have consistent interaction with different EU Institutions, to promote allergy awareness.
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback